Methoxy polyethylene glycol-epoetin beta Active Not Recruiting Phase 3 Trials for Anemia Associated With Chronic Kidney Disease (CKD) Treatment

Active Not RecruitingTreatment3 IdentifierTitleDrugs
NCT04707768Study Evaluating the Efficacy and Safety of Dose Conversion From a Long-acting Erythropoiesis-stimulating Agent (Mircera®) to Three Times Weekly Oral Vadadustat for the Maintenance Treatment of Anemia in Hemodialysis Subjects